covid 19 News and Research

RSS

Finnish study highlights the need for mRNA COVID vaccine booster shots

A register-based cohort study of the effectiveness of COVID-19 vaccines was performed to help decision-making on providing booster doses to social and healthcare workers (HCWs) like nurses, physicians, dentists, and other professionals in Finland. In addition, it estimated the vaccine effectiveness after the second dose. This study is published on the medRxiv* preprint server.

9 Nov 2021

COVID-19 vaccination strategies that minimize R0 may offer greater protection to vulnerable age groups

In this study, researchers aimed at finding the minimum vaccination rate for each age group that guaranteed the basic reproduction number R0 was less than 1, thus stabilizing the dynamics at the disease-free equilibrium.

9 Nov 2021

Study: Most pediatric cancer patients have mild COVID-19 and make full recovery

Most children and adolescents with cancer have mild COVID-19 disease and make a full recovery, a new study has found. But pediatric cancer patients with underlying health conditions, severe infections and low white blood cell counts were significantly more likely to have severe disease.

9 Nov 2021

Favourable meta-analysis of inhaled corticosteroids in COVID-19 outpatients

Two open-label randomized controlled trials (RCTs) on the use of inhaled corticosteroids such as budesonide in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients have helped garner attention towards inhaled corticosteroids as a safe and inexpensive treatment method in non-hospitalized SARS-CoV-2 patients.

9 Nov 2021

Birmingham Biotech partners with University of Birmingham to commercialize novel anti-viral nasal spray

Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19.

9 Nov 2021

US college students with disabilities generallt ill-informed about COVID-19 vaccines

The COVID-19 pandemic has drastically changed how educational institutions operate, including changes in the mode of learning and additional safety protocols for students, staff, faculty, and other stakeholders on campus. In addition, the development of COVID-19 vaccines has catalyzed the ability of campuses to re-open their doors to students and faculty.

9 Nov 2021

Elusive white blood cells play a role in impaired T cell functions and counts in people with HIV

In a groundbreaking study of people living with HIV, University of Alberta researchers found that elusive white blood cells called neutrophils play a role in impaired T cell functions and counts, as well as the associated chronic inflammation that is common with the virus.

9 Nov 2021

The impact of interventions and contact patterns on SARS-CoV-2 transmission

A recent study investigates the impact of varying interventions, consequent contact patterns, and the transmissibility of SARS-CoV-2.

9 Nov 2021

African healthcare workers suffer from COVID-19-induced stress, burnout

The pandemic could worsen in Sub-Saharan Africa if healthcare workers leave their jobs because of fear of COVID-19, stress, burnout and poor remuneration, a study suggests.

9 Nov 2021

A measles-vectored COVID-19 vaccine induces strong immunity in animal model

A new study explores the potential of MV-based vaccines targeting the S protein of SARS-CoV-2.

9 Nov 2021

COVID-19 and loss of sense of smell

A recent review examines the high susceptibility of the olfactory epithelium to SARS-CoV-2 infection.

9 Nov 2021

Psychiatric drug prevents some of the most serious complications of COVID-19, study finds

Leonard Imbula of the Healthy Mind Lab at Washington University School of Medicine in St. Louis holds a bottle of fluvoxamine, a psychiatric drug that has been shown, in a pair of studies conducted on two continents, to be an effective treatment for people sick with COVID-19.

9 Nov 2021